Global Ankle Replacement Devices Market - 2024-2031

Global Ankle Replacement Devices Market - 2024-2031

Global ankle replacement devices market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031.

Ankle replacement devices also known as total ankle arthroplasty or total ankle replacement, are orthopedic implants designed to replace a damaged or arthritic ankle joint with a prosthesis. These devices are used to restore mobility, alleviate pain and improve function in patients suffering from severe ankle arthritis, post-traumatic arthritis or other conditions that have led to significant joint degeneration.

Ankle replacement surgery involves removing the damaged bone and cartilage from the ankle joint and replacing it with prosthetic components made of metal (titanium), plastic (polyethylene) or ceramic materials. The components typically include a tibial component that replaces the top of the tibia, a talar component that replaces the bottom of the talus (ankle bone) and in some cases, a plastic spacer or bearing that fits between the tibial and talar components to allow for smooth movement.

Market Dynamics: Drivers

Rising advancements in ankle replacement devices

The rising advancements in ankle replacement devices are expected to drive the market over the forecast period. Advancements in surgical techniques and instrumentation enable orthopedic surgeons to perform ankle replacement surgeries with greater precision and minimal tissue disruption. There is an evolving technologies for the total ankle systems that are designed to optimize long-term device stability.

For instance, in January 2023, restor3d successfully implanted the company’s Kinos Axiom Total Ankle System featuring TIDAL Technology and launched the mobile companion App for the r3id Personalized Surgery platform. Recently, restor3d merged with Kinos Medical, a specialized ankle replacement company. The Kinos Axiom Total Ankle System, a revolutionary innovation in total ankle arthroplasty, features TIDAL Technology. TIDAL Technology is restor3d’s interconnected porous architecture, which is designed to optimize bone in-growth and fixation for long-term implant stability. Combined with the biomechanics of the Kinos Axiom, this proprietary bone-implant interface of the 3D-printed tibial and talar implants maximizes cortical bone contact to deliver functionality and longevity of the prosthesis.

Ongoing research and development efforts lead to the creation of ankle replacement devices with enhanced designs. These implants aim to better replicate the natural anatomy and function of the ankle joint, resulting in improved outcomes for patients in terms of range of motion, stability and longevity. Due to the various benefits offered by these devices, many market players are focussing on the development of these ankle systems with advanced features followed by FDA approvals.

For instance, on December 05, 2023, Exactech released that its subsidiary, BlueOrtho has received 510(k) clearance from the Food and Drug Administration for ExactechGPS Ankle, the world’s first surgical navigation system for total ankle arthroplasty (TAA). GPS Ankle is a first-of-its-kind technology, which connects the preoperative plan with real-time intraoperative instrument guidance and confirms that resections meet the surgical plan. The system uses proprietary active tracker technology and a compact touchscreen tablet in the sterile field to provide surgeons with dynamic intraoperative feedback throughout their cases.

Further, rising FDA approvals for novel devices, increasing clinical trials to develop more advanced ankle systems, increasing awareness about ankle replacement devices and technological advancements in the development of innovative ankle systems with advanced features are the factors expected to drive the market over the forecast period.

Restraints

Factors such as complications and risks associated with ankle replacement devices such as damage to nearby nerves, bleeding, loosening of the artificial components, which might eventually need follow-up surgery, blood clots and infection among others, the high cost of the ankle replacement procedures and unmet needs are the factors expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global ankle replacement devices market is segmented based on type, material, end-user and region.

The STAR (Scandinavian Total Ankle Replacement) segment accounted for approximately 45.5% of the ankle replacement devices market share

The STAR (Scandinavian Total Ankle Replacement) segment is expected to hold the largest market share over the forecast period. STAR is one of the first total ankle replacement systems in the market and carries a substantial amount of clinical data over many years demonstrating strong performance. Intended for use to replace a painful arthritic ankle joint due to osteoarthritis, post-traumatic arthritis or rheumatoid arthritis, STAR’s modular components and positional forgiveness allow for 225 patient-matched configurations with just one surgical technique.

The STAR implant is designed to closely mimic the natural anatomy and kinematics of the ankle joint. Its anatomical design aims to restore a more physiological range of motion and function, resulting in improved patient satisfaction and long-term outcomes. There is an increasing collaborations and acquisitions between the market players for the market expansion of these devices.

For instance, in December 2020, DJO LLC completed the acquisition of total ankle and finger arthroplasty product lines from international medical technology company Stryker. The acquisition includes the STAR total ankle arthroplasty system, a preferred technology worldwide because of its deep and leading clinical outcomes research. Ankle replacements in the U.S. more than doubled than the previous years, in part because ankle implants are becoming the treatment of choice over fusion surgery. The STAR ankle is a mobile-bearing total ankle replacement in the U.S. market approved for uncemented use, making it a preferred choice for surgeons and patients who want to help restore mobility.

Geographical Analysis

North America accounted for approximately 42.1% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and rising FDA approvals for innovative and advanced ankle replacement devices. North America especially the United States is a known hub for its strong presence of major players such as various medical device companies like Zimmer Biomet Holdings, Inc., Restor3d, Inc., Exactech and others. This presence of major players in the region developing the more advanced and patient-specific ankle replacement devices, which is expanding the market growth in the region.

For instance, on February 05, 2024, Restor3d, Inc., a provider of patient-specific musculoskeletal implants based in Durham, North Carolina, USA, launched its additively manufactured foot and ankle products during the American College of Foot & Ankle Surgeons (ACFAS) Annual Conference held in Tampa, Florida. The launch included the patient-specific Total Talus Replacement System and the line extension to the Kinos Axiom Total Ankle Replacement System, the Kinos X-Stem and Tall featuring a right angle drill for controlled stem preparation.

There is an increasing FDA approvals for ankle replacement devices, which is expected to drive the market in the region. For instance, on October 26, 2023, Exactech, cleared the FDA 510(k) clearance of its new 3D-printed tibial implants, the Vantage Ankle 3D and 3D+. This is the second recent clearance for the broader Vantage Total Ankle System, following Activit-E, a new advanced vitamin E polyethylene, which received clearance from the Food and Drug Administration last month.

Competitive Landscape

The major global players in the ankle replacement devices market include Zimmer Biomet Holdings, Inc, Stryker Corporation, Paragon 28, Inc., restor3d, CONMED Corporation, Smith+Nephew, DJO, LLC, Wright Medical Group N.V., Exactech, Inc. and VILEX, LLC among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global ankle replacement devices market. During the coronavirus disease 2019 (COVID-19) pandemic, many hospitals and healthcare facilities prioritized resources for treating COVID-19 patients. As a result, ankle replacement surgeries were postponed or canceled to conserve medical resources, minimize the risk of virus transmission and prioritize urgent and emergent cases. This led to a significant decline in the number of ankle replacement procedures performed, directly affecting the demand for ankle replacement devices.

Market Segmentation

By Type
• The Agility Ankle
• The INBONE Total Ankle
• Eclipse Total Ankle Replacement
• Salto Talaris Anatomic Ankle
• The STAR (Scandinavian Total Ankle Replacement)
• TNK Ankle
• Others

By Material
• Titanium
• Polyethylene
• Ceramic
• Others

By End-User
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Why Purchase the Report??
• To visualize the global ankle replacement devices market segmentation based on type, material, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of ankle replacement devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global ankle replacement devices market report would provide approximately 61 tables, 65 figures and 197 Pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies